Home › Funds › RA CAPITAL MANAGEMENT, L.P. › PBLS

RA CAPITAL MANAGEMENT, L.P. position in PBLS

PARABILIS MEDICINES INC · Health Care

RA CAPITAL MANAGEMENT, L.P. reported holding 29,177,964 shares of PBLS (PARABILIS MEDICINES INC) in its Q3 2026 13F filing — a position valued at US$942.2M, representing 9.70% of its reported portfolio and ranking #2 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed PBLS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)29.18M sh
Reported value held$942.16M
Portfolio Weight9.70%
First reportedQ2 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How RA CAPITAL MANAGEMENT, L.P.'s PBLS position evolved

RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in PBLS in Q2 2026 at 28,933,371 shares (US$791.9M). The position peaked in Q3 2026 at 29,177,964 shares, worth US$942.2M. Across 2 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 29,177,964 shares valued at US$942.2M — an increase of 244,593 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 28.93M $791.91M New
Q3 2026 29.18M $942.16M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PBLS and 13F data

PBLS (PARABILIS MEDICINES INC) is a Health Care company. 129 other funds we track also report a position in PBLS — the largest reported positions include ARCH Venture Management, LLC (US$207.1M), venBio Partners LLC (US$170.1M), Alphabet Inc. (US$158.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PBLS

All PBLS fund holders →

FAQ

How long has RA CAPITAL MANAGEMENT, L.P. held PBLS?

RA CAPITAL MANAGEMENT, L.P. has disclosed PBLS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is RA CAPITAL MANAGEMENT, L.P.'s current position in PBLS?

As of Q3 2026, RA CAPITAL MANAGEMENT, L.P. holds 29.18M shares of PBLS (PARABILIS MEDICINES INC), valued at $942.16M, representing 9.70% of its reported portfolio and ranking #2.

Has RA CAPITAL MANAGEMENT, L.P. been buying or selling PBLS?

In the latest 13F filing (Q3 2026), RA CAPITAL MANAGEMENT, L.P. increased its position in PBLS. The position peaked in Q3 2026 at 29.18M shares.

Which other funds hold PBLS?

Other major institutional holders of PBLS include ARCH Venture Management, LLC, venBio Partners LLC, Alphabet Inc., among 129 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.